GlassScriptOgsiveo
Payments companies reported to CMS as associated with Ogsiveo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Ogsiveo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Ogsiveo
These are the largest totals companies reported as associated with Ogsiveo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Noah Federman | Los Angeles, CA | Pediatric Hematology-Oncology | $136,749.35 |
| Dipak Ramkumar | Phoenix, AZ | Surgical Oncology | $97,802.17 |
| Pedro Hermida De Viveiros | Chicago, IL | Hematology & Oncology | $97,349.79 |
| Zsila Sadighi | Houston, TX | Neurology (Psychiatry & Neurology) | $53,793.36 |
| Seth Pollack | Chicago, IL | Hematology & Oncology | $45,762.07 |
| Sajeve Thomas | Orlando, FL | Hematology & Oncology | $36,939.90 |
| Matthew Dicaprio | Schenectady, NY | Sports Medicine (Orthopaedic Surgery) | $31,476.59 |
| Kamalesh Sankhala | Beverly Hills, CA | Medical Oncology | $31,177.23 |
| Bassan Allan | Fort Myers, FL | Surgical Oncology | $29,164.51 |
| Robert Randall | Sacramento, CA | Orthopaedic Surgery | $19,139.73 |
Prescribed Ogsiveo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.